Suppliers / Compounds & building blocks

Archetype
Cambridge, MA, United States · archetypetx.com
Archetype Therapeutics is an AI-native biotech company focused on patient-centric drug discovery. It uses patient clinicogenomic data, generative chemogenomics, and real-world evidence to screen and develop therapeutics for diseases including mCRPC, early-stage lung adenocarcinoma, metastatic melanoma, and idiopathic pulmonary fibrosis. The company works with partners across the healthcare and life sciences ecosystem.
They take quote requests by email.
What they offer
Patient-centric drug discovery
Uses patient clinicogenomic data and AI to link disease biology with clinical outcomes and identify therapeutic candidates.
In silico molecule screening
Screens billions of drug-like molecules virtually against patient-derived biological states to find candidates likely to improve outcomes.
Generative chemogenomics
Applies generative AI to design and evaluate molecules in the context of disease-specific biology.
Clinical outcome prediction
Predicts clinical trial outcomes and drug impact using disease models built from patient data.
What they work on
- Services
- Small molecule
- Capacity
- billions of drug-like molecules screened per day
- Turnaround
- in just days
Similar suppliers. 2bind Pharma Services, AAPharmaSyn, Aberjona Laboratories, Acellera
Found in a contract services directory. Listing built from archetypetx.com. Work here? Claim this listing.